Etiometry Raises $9M in Series A-3 Funding

Etiometry, a Boston, MA-based provider of clinical decision-support software for the intensive care environment, raised $9M in Series A-3 funding. The round was led by SKK 9i Ventures, with participation from Shamrock Holdings and other healthcare investors. Led by Shane Cooke, CEO, Etiometry provides clinical decision-support software for the intensive care environment. The software aggregates patients’ vital signs from multiple sources into one streamlined platform to help clinicians understand evolving clinical risks and make data-driven patient care decisions. To support the commercial expansion, Etiometry expanded its leadership team with three new hires: